Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

NCT03444038 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
85
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neurocrine Biosciences